Approaches to the management of functional tricuspid regurgitation

Jason H Rogers, Steven F. Bolling

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Functional tricuspid regurgitation (FTR) is an acquired valvular abnormality that is most frequently encountered during the evaluation and operative management of left-sided heart failure and left heart valve disease. Observational studies have demonstrated that uncorrected significant FTR during mitral valve surgery can result in inferior early and late outcomes due to progression of FTR and underlying right heart failure. The 2012 ESC/EACTS and 2014 ACC/AHA guidelines strongly encourage the surgical correction of greater than mild tricuspid regurgitation or tricuspid annular dilation greater than 4 cm in patients undergoing left-sided valve surgery. Prospective randomized trials are needed to bolster the evidence behind the current recommendations. Percutaneous therapies in development may eventually result in less invasive options for treating FTR.

Original languageEnglish (US)
Pages (from-to)665-676
Number of pages12
JournalJournal of Comparative Effectiveness Research
Volume4
Issue number6
DOIs
StatePublished - Nov 1 2015

Fingerprint

Tricuspid Valve Insufficiency
Heart Failure
Heart Valve Diseases
Mitral Valve
Observational Studies
Dilatation
Guidelines

Keywords

  • functional tricuspid regurgitation
  • outcomes
  • percutaneous valve therapies
  • surgery
  • tricuspid annuloplasty

ASJC Scopus subject areas

  • Health Policy

Cite this

Approaches to the management of functional tricuspid regurgitation. / Rogers, Jason H; Bolling, Steven F.

In: Journal of Comparative Effectiveness Research, Vol. 4, No. 6, 01.11.2015, p. 665-676.

Research output: Contribution to journalArticle

@article{05edfe1ed4f94b43b91ec22404cf9ebd,
title = "Approaches to the management of functional tricuspid regurgitation",
abstract = "Functional tricuspid regurgitation (FTR) is an acquired valvular abnormality that is most frequently encountered during the evaluation and operative management of left-sided heart failure and left heart valve disease. Observational studies have demonstrated that uncorrected significant FTR during mitral valve surgery can result in inferior early and late outcomes due to progression of FTR and underlying right heart failure. The 2012 ESC/EACTS and 2014 ACC/AHA guidelines strongly encourage the surgical correction of greater than mild tricuspid regurgitation or tricuspid annular dilation greater than 4 cm in patients undergoing left-sided valve surgery. Prospective randomized trials are needed to bolster the evidence behind the current recommendations. Percutaneous therapies in development may eventually result in less invasive options for treating FTR.",
keywords = "functional tricuspid regurgitation, outcomes, percutaneous valve therapies, surgery, tricuspid annuloplasty",
author = "Rogers, {Jason H} and Bolling, {Steven F.}",
year = "2015",
month = "11",
day = "1",
doi = "10.2217/cer.15.46",
language = "English (US)",
volume = "4",
pages = "665--676",
journal = "Journal of Comparative Effectiveness Research",
issn = "2042-6305",
publisher = "Future Medicine Ltd.",
number = "6",

}

TY - JOUR

T1 - Approaches to the management of functional tricuspid regurgitation

AU - Rogers, Jason H

AU - Bolling, Steven F.

PY - 2015/11/1

Y1 - 2015/11/1

N2 - Functional tricuspid regurgitation (FTR) is an acquired valvular abnormality that is most frequently encountered during the evaluation and operative management of left-sided heart failure and left heart valve disease. Observational studies have demonstrated that uncorrected significant FTR during mitral valve surgery can result in inferior early and late outcomes due to progression of FTR and underlying right heart failure. The 2012 ESC/EACTS and 2014 ACC/AHA guidelines strongly encourage the surgical correction of greater than mild tricuspid regurgitation or tricuspid annular dilation greater than 4 cm in patients undergoing left-sided valve surgery. Prospective randomized trials are needed to bolster the evidence behind the current recommendations. Percutaneous therapies in development may eventually result in less invasive options for treating FTR.

AB - Functional tricuspid regurgitation (FTR) is an acquired valvular abnormality that is most frequently encountered during the evaluation and operative management of left-sided heart failure and left heart valve disease. Observational studies have demonstrated that uncorrected significant FTR during mitral valve surgery can result in inferior early and late outcomes due to progression of FTR and underlying right heart failure. The 2012 ESC/EACTS and 2014 ACC/AHA guidelines strongly encourage the surgical correction of greater than mild tricuspid regurgitation or tricuspid annular dilation greater than 4 cm in patients undergoing left-sided valve surgery. Prospective randomized trials are needed to bolster the evidence behind the current recommendations. Percutaneous therapies in development may eventually result in less invasive options for treating FTR.

KW - functional tricuspid regurgitation

KW - outcomes

KW - percutaneous valve therapies

KW - surgery

KW - tricuspid annuloplasty

UR - http://www.scopus.com/inward/record.url?scp=84948658907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84948658907&partnerID=8YFLogxK

U2 - 10.2217/cer.15.46

DO - 10.2217/cer.15.46

M3 - Article

C2 - 26535470

AN - SCOPUS:84948658907

VL - 4

SP - 665

EP - 676

JO - Journal of Comparative Effectiveness Research

JF - Journal of Comparative Effectiveness Research

SN - 2042-6305

IS - 6

ER -